🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.3871
-0.0228 (-5.56%)
At close: Nov 19, 2026, 4:00 PM EST
0.4000
+0.0129 (3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST

Coherus Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
53.4988.88125.99102.8963.55417.2
Short-Term Investments
30.1483.25-14.86128.13-
Cash & Short-Term Investments
83.63172.13125.99117.75191.68417.2
Cash Growth
-56.37%36.62%7.00%-38.57%-54.05%-22.91%
Accounts Receivable
13.7217.82111.32260.52109.96123.02
Other Receivables
0.20.611.01---
Receivables
13.9218.42122.33260.52109.96123.02
Inventory
4.823.174.2162.6138.7937.64
Prepaid Expenses
11.7612.9916.8834.7640.824.46
Other Current Assets
--72.18---
Total Current Assets
114.13206.71341.58475.63381.23602.32
Property, Plant & Equipment
0.654.37.0911.0314.4416.01
Goodwill
---0.940.940.9
Other Intangible Assets
44.3646.2453.6570.734.992.66
Other Long-Term Assets
11.961.146.2171.2779.2457.44
Total Assets
171.1258.34448.53629.6480.85679.33

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
14.519.9228.4635.2211.5316.16
Accrued Expenses
39.5563.58227.04291.11122.85145.68
Current Portion of Long-Term Debt
--1.15---
Current Portion of Leases
1.951.831.692.154.323.49
Other Current Liabilities
19.6465.0724.653.3--
Total Current Liabilities
75.64140.39282.98331.77138.69165.33
Long-Term Debt
67.651.08292.52473.37471.06408.28
Long-Term Leases
-1.463.295.335.057.25
Long-Term Deferred Tax Liabilities
1.11.11.11.1--
Other Long-Term Liabilities
1.513.310.6311.463.470.75
Total Liabilities
145.86197.33580.52823.03618.27581.61

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.010.010.010.010.01
Additional Paid-In Capital
1,5071,4441,4191,3861,2041,148
Retained Earnings
-1,481-1,383-1,551-1,580-1,342-1,050
Comprehensive Income & Other
-0.29-0.2-0.28-0.25-0.25-0.27
Total Common Equity
25.2561.01-131.99-193.43-137.4297.73
Shareholders' Equity
25.2561.01-131.99-193.43-137.4297.73
Total Liabilities & Equity
171.1258.34448.53629.6480.85679.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
69.5554.36298.65480.84480.42419.02
Net Cash (Debt)
14.08117.76-172.66-363.09-288.74-1.83
Net Cash Growth
-89.75%-----
Net Cash Per Share
0.101.01-1.51-3.86-3.72-0.02
Filing Date Shares Outstanding
154.54149.89115.9112.7179.6177.28
Total Common Shares Outstanding
154.53121.15115.61112.2278.8576.93
Working Capital
38.4966.3258.6143.86242.54437
Book Value Per Share
0.160.50-1.14-1.72-1.741.27
Tangible Book Value
-19.1214.78-185.64-265.1-143.3594.16
Tangible Book Value Per Share
-0.120.12-1.61-2.36-1.821.22
Machinery
-10.8218.0717.7317.3916.04
Construction In Progress
----0.70.39
Leasehold Improvements
-5.765.755.756.25.94
SEC Filings: 10-K · 10-Q